Relationship of an hRAD54 gene polymorphism (2290 C/T) in an Ecuadorian population with chronic myelogenous leukemia
2010

hRAD54 Gene Polymorphism and Chronic Myelogenous Leukemia

Sample size: 239 publication Evidence: moderate

Author Information

Author(s): César Paz-y-Miño, Andrés López-Cortés, María José Muñoz, Bernardo Castro, Alejandro Cabrera, María Eugenia Sánchez

Primary Institution: Instituto de Investigaciones Biomédicas, Facultad de Ciencias de la Salud, Universidad de las Américas, Quito, Ecuador

Hypothesis

Is there a relationship between the hRAD54 gene polymorphism (2290 C/T) and chronic myelogenous leukemia in an Ecuadorian population?

Conclusion

The study suggests a possible link between the 2290 C/T polymorphism of the hRAD54 gene and chronic myelogenous leukemia.

Supporting Evidence

  • The 2290 C/T polymorphism has frequencies of 0.1 for both leukemia and control groups.
  • In the CML subgroup, the frequency was 0.14, showing significant differences from the control group.
  • No significant differences were found between the ALL subgroup and the control group.

Takeaway

Scientists looked at a gene that might be linked to a type of blood cancer called chronic myelogenous leukemia, and they found some interesting connections.

Methodology

The hRAD54 gene polymorphism was analyzed using PCR-SSCP method in 239 samples, including leukemia patients and a control group.

Limitations

The sample size is not large, which may limit the interpretation of the results.

Participant Demographics

239 Ecuadorian individuals, including 137 with leukemia (61 ALL, 1 CLL, 15 AML, 60 CML) and 102 healthy controls.

Statistical Information

P-Value

p < 0.05 for CML vs control, p > 0.05 for ALL vs control

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1590/S1415-47572010005000095

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication